Antitumor effect of TNP-470 on glial tumors transplanted in rats

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 71-76

  Isobe, Naoyuki ^a   Uozumi, Tohru ^a   Kurisu, Kaoru ^a   Kawamoto, Keiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

9 L gliosarcoma; Angiogenesis; Loss of body weight; TNP 470

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CANCER TRANSPLANTATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLIOMA; HUMAN; HUMAN CELL; INTRACRANIAL TUMOR; MEDULLOBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BODY WEIGHT; BRAIN NEOPLASMS; CELL DIVISION; CYCLOHEXANES; ENDOTHELIUM, VASCULAR; FEMALE; GLIOSARCOMA; INJECTIONS, SUBCUTANEOUS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 0029993625     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Folkman J: Tumor angiogenesis: therapeutic implications. New Engl J Med 285. 1182-1186, 1971.
2. Folkman J Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175: 409-416, 1972.
3. DiPaolo JA, Tarbell DS and Moore GE: Studies on the carcinolytic activity of fumagillin and some of its derivatives. Antibiotics Annual: 541-547, 1958-1959.
4. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H and Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348, 555-557, 1990.
5. Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D and Folkman J: Potent antiangiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 174: 1070-1076, 1991.
6. Marui S, Itoh F, Kozai Y, Sudo K and Kishimoto S: Chemical modification of Fumagillin. I. 6-O-Acyl, 6-O-Sulfonyl, 6-O-Alkyl, and 6-O-(N-Substituted-carbamoyl) fumagillols. Chem Pharm Bull 40: 96-101, 1992.
7. Marui S and Kishimoto S: Chemical modification of Fumagillin. II. 6-amino-6-deoxyfumagillol and its derivatives. Chem Pharm Bull 40: 575-579, 1992.
8. 1,2,3. Science 113: 202-203, 1951.
9. Yamaoka M, Yamamoto T, Ikeyama S, Sudo K and Fujita T: Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Rec 53: 5233-5236. 1993.
10. Yanase T, Tamura M, Fujita K, Kodama S and Tanaka K: Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 53: 2566-2570, 1993.
11. Takamiya Y, Friedlander RM, Brem H, Marick A and Martuza RL: Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. J Neurosurg 78: 470-476, 1993.
12. Bailey P and Cushing H: Medulloblatoma cerebelli. A common type of midcerebellar glioma of childhood. Arch Neurol Psychiat 14: 192-224, 1925.
13. Mikami T, Kurisu K, Kawamoto K, Kiya K, Mukada K, Hotta T, Ogasawara H, Sugiyama K and Uozumi T: Establishment and characterization of human medulloblastoma xenograft line. Hiroshima J Med Sci 40: 41-45, 1991.
14. Brem H and Folkman J: Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 141: 427-439, 1975.
15. Crum R, Szabo S and Folkman J: A new class of steroids inhibites angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375-1378, 1985.
16. Brem SS, ZagZag D, Tsanaclis AMC, Gately S, Elkouby M-P and Brien SE: Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Am J Pathol 137: 1121-1142, 1990.
17. Folkman J: What is the evidence that tumors are angiogenesis dependent. JNCI 82: 4-6, 1990.
18. Niitsu Y, Watanabe N, Sone H, Neda H, Yamauchi N and Urushizaki I: Mechanism of the cytotoxic effect of tumor necrosis factor. Jpn J Cancer Res 76: 1193-1197, 1985.
19. Niitsu Y, Watanabe N, Sone H, Neda H, Yamauchi N, Maeda M and Urushizaki I: Analysis of the TNF receptor on KYM cells by binding assay and affinity cross-linking. J Biol Response Mod 7: 276-282, 1988.
20. Kurisu K: Experimental studies on the antitumor effect of recominant human tumor necrosis factor against malignant tumors -2. Histological analysis of the action mechanism of recombinant human necrosis factor. Hiroshima J Med Sci 37: 565-576, 1989.